BGC > Produktsuche > Doravirine | 1338225-97-0

Molecular Formula: C17H11ClF3N5O3
Molecular Weight: 425.7491496

Description:
Doravirine is a non-nucleoside reverse transcriptase inhibitor under development of Merck & Co. IC 50 value is 12 nM against the wild type, 21nM against K103N, 31 nM against Y181C, 33nM against K103N/Y181C mutant viruses in vitro. MK-1439 exhibited similar antiviral activities against 10 different HIV-1 subtype viruses. Phase III for the treatment of HIV-1 infections is on-going.

• Molecular Weight:425.75
• Purity:98%

Molecular Formula:
C17H11ClF3N5O3
Canonical SMILES:
Cn1c(n[nH]c1=O)Cn2ccc(c(c2=O)Oc3cc(cc(c3)Cl)C#N)C(F)(F)F
InChI:
1S/C17H11ClF3N5O3/c1-25-13(23-24-16(25)28)8-26-3-2-12(17(19,20)21)14(15(26)27)29-11-5-9(7-22)4-10(18)6-11/h2-6H,8H2,1H3,(H,24,28)
InChIKey:
ZIAOVIPSKUPPQW-UHFFFAOYSA-N
Solubility:
Soluble in DMSO
Appearance:
Powder
Application:
HIV-1 infections
Storage: -20°C Freezer
Synonyms:
MK-1439; MK 1439; MK1439; MK-1439-019;3-Chloro-5-((1-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl)-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl)oxy)benzonitrile